STAT3 and cholangiocarcinoma: In a study by Chen and colleagues, allicin (40 μM) was found to inhibit the proliferation and invasion of cholangiocarcinoma (CCA) cells by targeting STAT3, a key transcription factor involved in cell proliferation [133].